Skip to main content
. Author manuscript; available in PMC: 2019 Jun 3.
Published in final edited form as: Int J Oncol. 2010 Oct;37(4):963–971. doi: 10.3892/ijo_00000747

Figure 5.

Figure 5.

Lack of enhanced growth inhibition by combined zebularine and depsipeptide treatment in lung and breast cancer cells with deleted CDKN2A gene. (A) H226 and (B) H1264 lung cancer cell lines and (C) MDA-MB231 breast cancer cell line were treated with zebularine (Zeb) alone, depsipeptide (Depsi) alone, or a combination at the indicated concentrations. The amount of cell growth was measured by MTS assay and the growth inhibition of treated cells is presented as a percentage of surviving cells as compared to untreated controls.